Literature DB >> 2673542

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.

J A DeCaprio1, J W Ludlow, D Lynch, Y Furukawa, J Griffin, H Piwnica-Worms, C M Huang, D M Livingston.   

Abstract

The retinoblastoma susceptibility gene product, Rb, is suspected to suppress cell growth. Rb is a 110-114 kd nuclear phosphoprotein. We have previously demonstrated that SV40 T antigen binds only to unphosphorylated Rb, and not pp112-114Rb, the family of phosphorylated Rb. Here we demonstrate the cell cycle-dependent phosphorylation of Rb. In G0/G1 cells, virtually all the Rb is unphosphorylated. In contrast, during S and G2, it is largely, if not exclusively, phosphorylated. Rb phosphorylation occurs at the G1/S boundary in several cell types tested. A 14 residue peptide, corresponding to the SV40 T domain required for transformation, is able to compete effectively with SV40 T for binding to p110Rb. We propose a model to explain how Rb may suppress cell growth by acting as a cell cycle regulatory element.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673542     DOI: 10.1016/0092-8674(89)90507-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  249 in total

1.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 2.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

3.  Skip interacts with the retinoblastoma tumor suppressor and inhibits its transcriptional repression activity.

Authors:  Tulasiram Prathapam; Christian Kühne; Lawrence Banks
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

4.  p53 functions as a cell cycle control protein in osteosarcomas.

Authors:  L Diller; J Kassel; C E Nelson; M A Gryka; G Litwak; M Gebhardt; B Bressac; M Ozturk; S J Baker; B Vogelstein
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

5.  The third subunit of protein phosphatase 2A (PP2A), a 55-kilodalton protein which is apparently substituted for by T antigens in complexes with the 36- and 63-kilodalton PP2A subunits, bears little resemblance to T antigens.

Authors:  D C Pallas; W Weller; S Jaspers; T B Miller; W S Lane; T M Roberts
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity.

Authors:  S E Abraham; M C Carter; E Moran
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

7.  Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins.

Authors:  N Dyson; P Guida; K Münger; E Harlow
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

Review 8.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

9.  Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M.

Authors:  J Y Lee; L G Leonhardt; L M Obeid
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

10.  Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest.

Authors:  F M Jault; J M Jault; F Ruchti; E A Fortunato; C Clark; J Corbeil; D D Richman; D H Spector
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.